{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:53:46Z","timestamp":1790798026493,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8073","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,7,24]]},"DOI":"10.1038\/s41586-025-09070-3","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:02:30Z","timestamp":1748430150000},"page":"1097-1106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking"],"prefix":"10.1038","volume":"643","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-678X","authenticated-orcid":false,"given":"Michela","family":"Milani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-6967","authenticated-orcid":false,"given":"Anna","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8115-4093","authenticated-orcid":false,"given":"Marta","family":"Perez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa Jofra","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Zecchillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Zonari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ottonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Basso-Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Canepari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Volpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Iannello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-1429","authenticated-orcid":false,"given":"Valentina","family":"Capo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Seffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5280-5677","authenticated-orcid":false,"given":"Fabio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-2854","authenticated-orcid":false,"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Ormoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Brombin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Forlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Filibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-6067","authenticated-orcid":false,"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-7013","authenticated-orcid":false,"given":"Juan Antonio","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5424-5543","authenticated-orcid":false,"given":"Paula","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-1717","authenticated-orcid":false,"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-997X","authenticated-orcid":false,"given":"Alessio","family":"Cantore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-527X","authenticated-orcid":false,"given":"Luigi","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"9070_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","volume":"22","author":"G Ferrari","year":"2021","unstructured":"Ferrari, G., Thrasher, A. J. & Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216\u2013234 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"9070_CR2","doi-asserted-by":"publisher","first-page":"e9958","DOI":"10.15252\/emmm.201809958","volume":"11","author":"L Naldini","year":"2019","unstructured":"Naldini, L. Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives. EMBO Mol. Med. 11, e9958 (2019).","journal-title":"EMBO Mol. Med."},{"key":"9070_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.stem.2023.04.014","volume":"30","author":"S Ferrari","year":"2023","unstructured":"Ferrari, S. et al. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell Stem Cell 30, 549\u2013570 (2023).","journal-title":"Cell Stem Cell"},{"key":"9070_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1126\/science.adj0997","volume":"381","author":"S Ferrari","year":"2023","unstructured":"Ferrari, S. & Naldini, L. A step toward stem cell engineering in vivo. Science 381, 378\u2013379 (2023).","journal-title":"Science"},{"key":"9070_CR5","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","volume":"128","author":"M Richter","year":"2016","unstructured":"Richter, M. et al. In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood 128, 2206\u20132217 (2016).","journal-title":"Blood"},{"key":"9070_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"9070_CR7","doi-asserted-by":"publisher","first-page":"eaav7325","DOI":"10.1126\/scitranslmed.aav7325","volume":"11","author":"M Milani","year":"2019","unstructured":"Milani, M. et al. Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Sci. Transl. Med. 11, eaav7325 (2019).","journal-title":"Sci. Transl. Med."},{"key":"9070_CR8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s44321-024-00072-8","volume":"16","author":"M Milani","year":"2024","unstructured":"Milani, M. et al. GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice. EMBO Mol. Med. 16, 1427\u20131450 (2024).","journal-title":"EMBO Mol. Med."},{"key":"9070_CR9","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ni1527","volume":"8","author":"K Takenaka","year":"2007","unstructured":"Takenaka, K. et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 8, 1313\u20131323 (2007).","journal-title":"Nat. Immunol."},{"key":"9070_CR10","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1172\/JCI31666","volume":"117","author":"A Aiuti","year":"2007","unstructured":"Aiuti, A. et al. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J. Clin. Invest. 117, 2233\u20132240 (2007).","journal-title":"J. Clin. Invest."},{"key":"9070_CR11","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1089\/hum.2017.175","volume":"28","author":"F Ferrua","year":"2017","unstructured":"Ferrua, F. & Aiuti, A. Twenty-five years of gene therapy for ADA-SCID: from bubble babies to an approved drug. Hum. Gene Ther. 28, 972\u2013981 (2017).","journal-title":"Hum. Gene Ther."},{"key":"9070_CR12","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1182\/blood-2012-05-432591","volume":"120","author":"A Cantore","year":"2012","unstructured":"Cantore, A. et al. Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice. Blood 120, 4517\u20134520 (2012).","journal-title":"Blood"},{"key":"9070_CR13","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood-2012-02-408591","volume":"120","author":"DA Carbonaro","year":"2012","unstructured":"Carbonaro, D. A. et al. Gene therapy\/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction. Blood 120, 3677\u20133687 (2012).","journal-title":"Blood"},{"key":"9070_CR14","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1182\/blood-2006-05-023507","volume":"108","author":"A Mortellaro","year":"2006","unstructured":"Mortellaro, A. et al. Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. Blood 108, 2979\u20132988 (2006).","journal-title":"Blood"},{"key":"9070_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116519","volume":"165","author":"V Capo","year":"2022","unstructured":"Capo, V., Abinun, M. & Villa, A. Osteoclast rich osteopetrosis due to defects in the TCIRG1 gene. Bone 165, 116519 (2022).","journal-title":"Bone"},{"key":"9070_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","volume":"26","author":"JC Scimeca","year":"2000","unstructured":"Scimeca, J. C. et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants. Bone 26, 207\u2013213 (2000).","journal-title":"Bone"},{"key":"9070_CR17","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/s41591-019-0550-z","volume":"25","author":"P Rio","year":"2019","unstructured":"Rio, P. et al. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia. Nat. Med. 25, 1396\u20131401 (2019).","journal-title":"Nat. Med."},{"key":"9070_CR18","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/S0140-6736(24)01880-4","volume":"404","author":"P Rio","year":"2025","unstructured":"Rio, P. et al. Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1\/2 (FANCOLEN-1) and long-term clinical trials. Lancet 404, 2584\u20132592 (2025).","journal-title":"Lancet"},{"key":"9070_CR19","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1182\/blood.V100.6.2032","volume":"100","author":"P Rio","year":"2002","unstructured":"Rio, P. et al. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. Blood 100, 2032\u20132039 (2002).","journal-title":"Blood"},{"key":"9070_CR20","doi-asserted-by":"publisher","first-page":"e142842","DOI":"10.1172\/JCI142842","volume":"132","author":"JA Casado","year":"2022","unstructured":"Casado, J. A. et al. Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. J. Clin. Invest. 132, e142842 (2022).","journal-title":"J. Clin. Invest."},{"key":"9070_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/cyto.a.23148","volume":"91","author":"L Basso-Ricci","year":"2017","unstructured":"Basso-Ricci, L. et al. Multiparametric whole blood dissection: a one-shot comprehensive picture of the human hematopoietic system. Cytometry A 91, 952\u2013965 (2017).","journal-title":"Cytometry A"},{"key":"9070_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.stem.2020.08.001","volume":"27","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Single-cell analysis of neonatal HSC ontogeny reveals gradual and uncoordinated transcriptional reprogramming that begins before birth. Cell Stem Cell 27, 732\u2013747 (2020).","journal-title":"Cell Stem Cell"},{"key":"9070_CR23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.cell.2024.02.002","volume":"187","author":"A Collins","year":"2024","unstructured":"Collins, A. et al. Maternal inflammation regulates fetal emergency myelopoiesis. Cell 187, 1402\u20131421 (2024).","journal-title":"Cell"},{"key":"9070_CR24","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1182\/blood.2023022666","volume":"143","author":"P Quaranta","year":"2024","unstructured":"Quaranta, P. et al. Circulating hematopoietic stem\/progenitor cells subsets contribute to human hematopoietic homeostasis. Blood 143, 1937\u20131952 (2024).","journal-title":"Blood"},{"key":"9070_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30102-3","volume":"13","author":"M Milani","year":"2022","unstructured":"Milani, M. et al. Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates. Nat. Commun. 13, 2454 (2022).","journal-title":"Nat. Commun."},{"key":"9070_CR26","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1182\/blood-2005-10-4047","volume":"107","author":"FR Santoni de Sio","year":"2006","unstructured":"Santoni de Sio, F. R., Cascio, P., Zingale, A., Gasparini, M. & Naldini, L. Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood 107, 4257\u20134265 (2006).","journal-title":"Blood"},{"key":"9070_CR27","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1634\/stemcells.2007-0705","volume":"26","author":"FR Santoni de Sio","year":"2008","unstructured":"Santoni de Sio, F. R. et al. Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. Stem Cells 26, 2142\u20132152 (2008).","journal-title":"Stem Cells"},{"key":"9070_CR28","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1182\/blood-2006-10-049312","volume":"109","author":"BD Brown","year":"2007","unstructured":"Brown, B. D. et al. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109, 2797\u20132805 (2007).","journal-title":"Blood"},{"key":"9070_CR29","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/hep.24230","volume":"53","author":"J Matrai","year":"2011","unstructured":"Matrai, J. et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 53, 1696\u20131707 (2011).","journal-title":"Hepatology"},{"key":"9070_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3324\/haematol.2019.238261","volume":"106","author":"V Capo","year":"2021","unstructured":"Capo, V. et al. Expanded circulating hematopoietic stem\/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis. Haematologica 106, 74\u201386 (2021).","journal-title":"Haematologica"},{"key":"9070_CR31","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1074\/jbc.273.9.5093","volume":"273","author":"MR Blackburn","year":"1998","unstructured":"Blackburn, M. R., Datta, S. K. & Kellems, R. E. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J. Biol. Chem. 273, 5093\u20135100 (1998).","journal-title":"J. Biol. Chem."},{"key":"9070_CR32","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/hmg\/9.12.1805","volume":"9","author":"NC Cheng","year":"2000","unstructured":"Cheng, N. C. et al. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum. Mol. Genet. 9, 1805\u20131811 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"9070_CR33","doi-asserted-by":"publisher","first-page":"eade3856","DOI":"10.1126\/scitranslmed.ade3856","volume":"15","author":"M Colantuoni","year":"2023","unstructured":"Colantuoni, M. et al. Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders. Sci. Transl. Med. 15, eade3856 (2023).","journal-title":"Sci. Transl. Med."},{"key":"9070_CR34","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41591-021-01389-4","volume":"27","author":"D Cesana","year":"2021","unstructured":"Cesana, D. et al. Retrieval of vector integration sites from cell-free DNA. Nat. Med. 27, 1458\u20131470 (2021).","journal-title":"Nat. Med."},{"key":"9070_CR35","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12859-017-1937-9","volume":"18","author":"G Spinozzi","year":"2017","unstructured":"Spinozzi, G. et al. VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites. BMC Bioinformatics 18, 520 (2017).","journal-title":"BMC Bioinformatics"},{"key":"9070_CR36","doi-asserted-by":"publisher","first-page":"bbac551","DOI":"10.1093\/bib\/bbac551","volume":"24","author":"G Pais","year":"2023","unstructured":"Pais, G. et al. ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications. Brief. Bioinform. 24, bbac551 (2023).","journal-title":"Brief. Bioinform."},{"key":"9070_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/bioinformatics\/bts004","volume":"28","author":"CC Berry","year":"2012","unstructured":"Berry, C. C. et al. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics 28, 755\u2013762 (2012).","journal-title":"Bioinformatics"},{"key":"9070_CR38","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","volume":"117","author":"A Biffi","year":"2011","unstructured":"Biffi, A. et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117, 5332\u20135339 (2011).","journal-title":"Blood"},{"key":"9070_CR39","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1373\/clinchem.2003.021576","volume":"49","author":"F Carlucci","year":"2003","unstructured":"Carlucci, F. et al. Capillary electrophoresis in diagnosis and monitoring of adenosine deaminase deficiency. Clin. Chem. 49, 1830\u20131838 (2003).","journal-title":"Clin. Chem."},{"key":"9070_CR40","doi-asserted-by":"publisher","first-page":"100242","DOI":"10.1016\/j.bonr.2020.100242","volume":"12","author":"E Palagano","year":"2020","unstructured":"Palagano, E. et al. Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis. Bone Rep. 12, 100242 (2020).","journal-title":"Bone Rep."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09070-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:09:49Z","timestamp":1757171389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09070-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":40,"journal-issue":{"issue":"8073","published-print":{"date-parts":[[2025,7,24]]}},"alternative-id":["9070"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09070-3","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.R. and J.A.B. receive funding and have licensed the PGK.FANCA-LV to Rocket Pharmaceuticals and are inventors on patents filed by CIEMAT, CIBERER and Fundaci\u00f3n Jim\u00e9nez D\u00edaz, and may be entitled to receive financial benefits from the licensing of such patents. J.A.B. is consultant of Rocket Pharmaceuticals, A.A. is the principal investigator of clinical trials with LV-transduced haematopoietic stem cells sponsored by Orchard Therapeutics or Fondazione Telethon. L.N. and A.C. are inventors on patent applications submitted by Fondazione Telethon or the San Raffaele Scientific Institute on LV technology for in vivo use related to the work presented in this paper. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}